Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Andritz AG stock logo
ADRZY
Andritz
$14.06
-2.7%
$13.46
$9.35
$14.62
$7.31B0.866,935 shs3,820 shs
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
$57.62
$57.62
$46.69
$57.69
$7.27B1.26250 shs82 shs
Mondi plc stock logo
MONDY
Mondi
$32.16
-0.2%
$30.83
$25.53
$41.67
$7.10B0.9715,653 shs7,647 shs
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$104.49
$90.36
$34.26
$105.60
$1.88B0.221,266 shs2,500 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Andritz AG stock logo
ADRZY
Andritz
+1.69%-0.41%+0.63%+12.89%+15.39%
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
0.00%0.00%0.00%0.00%0.00%
Mondi plc stock logo
MONDY
Mondi
-2.47%-2.41%+1.58%-1.71%-15.08%
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.00%+0.86%+29.15%+2.36%+235.45%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Andritz AG stock logo
ADRZY
Andritz
N/AN/AN/AN/AN/AN/AN/AN/A
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
N/AN/AN/AN/AN/AN/AN/AN/A
Mondi plc stock logo
MONDY
Mondi
N/AN/AN/AN/AN/AN/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.3618 of 5 stars
0.03.00.00.03.00.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Andritz AG stock logo
ADRZY
Andritz
2.00
HoldN/AN/A
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
0.00
N/AN/AN/A
Mondi plc stock logo
MONDY
Mondi
3.00
BuyN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PHMMF, MONDY, ADRZY, and BJINY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
Mondi plc stock logo
MONDY
Mondi
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/7/2025
Mondi plc stock logo
MONDY
Mondi
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
4/3/2025
Andritz AG stock logo
ADRZY
Andritz
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Outperform
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Andritz AG stock logo
ADRZY
Andritz
$9.37B0.78$1.83 per share7.69$4.49 per share3.13
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
$7.38B0.99$10.55 per share5.46$80.49 per share0.72
Mondi plc stock logo
MONDY
Mondi
$8.03B0.88$4.56 per share7.05$29.90 per share1.08
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$171.15M11.00$0.45 per share231.27$11.62 per share8.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Andritz AG stock logo
ADRZY
Andritz
$552.19M$1.0412.9012.90N/A5.90%23.10%6.10%7/31/2025 (Estimated)
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
$882.75M$6.998.247.13N/AN/AN/AN/AN/A
Mondi plc stock logo
MONDY
Mondi
-$165.59MN/A0.0011.531.67N/AN/AN/A7/31/2025 (Estimated)
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$1.23MN/A0.00N/AN/AN/AN/A7/28/2025 (Estimated)

Latest PHMMF, MONDY, ADRZY, and BJINY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Andritz AG stock logo
ADRZY
Andritz
$0.2191$0.19-$0.0291$0.19$1.80 billion$2.00 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Andritz AG stock logo
ADRZY
Andritz
$0.342.42%N/A32.69%N/A
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
$0.781.35%N/A11.16%N/A
Mondi plc stock logo
MONDY
Mondi
$1.976.13%N/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Andritz AG stock logo
ADRZY
Andritz
0.24
1.16
0.89
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
N/AN/AN/A
Mondi plc stock logo
MONDY
Mondi
0.36
2.06
1.32
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.14
2.55
2.01

Institutional Ownership

CompanyInstitutional Ownership
Andritz AG stock logo
ADRZY
Andritz
N/A
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
0.01%
Mondi plc stock logo
MONDY
Mondi
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/A

Insider Ownership

CompanyInsider Ownership
Andritz AG stock logo
ADRZY
Andritz
N/A
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
N/A
Mondi plc stock logo
MONDY
Mondi
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
1.88%
CompanyEmployeesShares OutstandingFree FloatOptionable
Andritz AG stock logo
ADRZY
Andritz
29,717520.00 millionN/ANot Optionable
BEIJING ENTPS H/S stock logo
BJINY
BEIJING ENTPS H/S
45,000126.21 millionN/ANot Optionable
Mondi plc stock logo
MONDY
Mondi
21,000220.71 millionN/ANot Optionable
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
50918.01 millionN/ANot Optionable

Recent News About These Companies

Exploring High Growth Tech Stocks in Europe April 2025
High Growth Tech Leads These 3 Top Stocks with Potential
Insider-Led Growth Stocks To Watch In December 2024
Pharma Mar S.A. Reduces Share Capital by Canceling Shares
Pharma Mar Achieves Legal Win in Aplidin Case

Media Sentiment Over Time

Andritz stock logo

Andritz OTCMKTS:ADRZY

$14.06 -0.39 (-2.70%)
As of 02:54 PM Eastern

Andritz AG provides plants, equipment, and services for pulp and paper industry, metalworking and steel industries, hydropower stations, and solid/liquid separation in the municipal and industrial sectors in Europe, North America, South America, China, Asia, and internationally. It operates through four segments: Pulp & Paper, Metals, Hydro, and Separation. The Pulp & Paper segment supplies technology, automation, and service solutions to produce pulp, paper, board, and tissue; boilers for power generation; flue gas cleaning systems; nonwovens technologies; panelboard production systems; and recycling, shredding, and energy solutions for various waste materials. The Metals segment provides technologies, plants, and digital solutions, including automation and software solutions, and process know-how and services; and solutions for the production and processing of flat products for welding systems and industrial furnaces, as well as services for the metals processing industry. The Hydro segment supplies electromechanical equipment and services for hydropower plants; offers plant diagnosis, refurbishment, modernization, and upgradation of existing hydropower plants; and pumps for irrigation, water supply, and flood control, as well as turbo generators. The Separation segment offers mechanical and thermal technologies, as well as services and related automation solutions for solid/liquid separation to serve chemical, environmental, food, mining, and minerals industries; and technologies and services to produce animal feed and biomass pellets. The company was founded in 1852 and is headquartered in Graz, Austria.

BEIJING ENTPS H/S stock logo

BEIJING ENTPS H/S OTCMKTS:BJINY

$57.62 0.00 (0.00%)
As of 04/3/2019

Beijing Enterprises Holdings Limited, an investment holding company, engages in piped gas, brewery, water and environmental, solid waste treatment, and other businesses primarily in Mainland China. Its Piped Gas Operation segment distributes and sells piped natural gas; provides natural gas transmission, and gas technology consultation and development services, as well as repair and maintenance services; surveys and plots underground construction projects; and constructs and installs gas pipelines and related equipment. The company's Brewery Operation segment produces, distributes, and sells brewery products. Its Water and Environmental segment constructs sewage and water treatment plants and other infrastructural facilities; provides construction services for renovation projects; offers sewage treatment, and water treatment and distribution services, as well as consultancy services; and licenses technical know-how related to sewage treatment. The company's Solid Waste Treatment segment is involved in the construction and operation of waste incineration plants; waste treatment; sale of electricity; generation of heat and stream from waste incineration. Its Corporate and Others segment offers consultation and property investment services. Beijing Enterprises Holdings Limited was founded in 1997, and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange. The company is based in Wan Chai, Hong Kong. Beijing Enterprises Holdings Limited is a subsidiary of Beijing Enterprises Group (BVI) Company Limited.

Mondi stock logo

Mondi OTCMKTS:MONDY

$32.16 -0.05 (-0.16%)
As of 03:50 PM Eastern

Mondi plc, together with its subsidiaries, engages in the manufacture and sale of packaging and paper solutions in Africa, Western Europe, Emerging Europe, North America, South America, Asia, Australia, and internationally. The company operates in three segments: Corrugated Packaging, Flexible Packaging, and Uncoated Fine Paper. The Corrugated Packaging segment provides virgin and recycled containerboards for fresh fruit packaging and heavy and fragile goods transport packaging applications; and corrugated solutions, such as corrugated boxes and packaging products. The Flexible Packaging segment offers sack kraft paper, paper bags, specialty kraft paper, consumer flexibles, and functional paper and films. The Uncoated Fine Paper segment provides uncoated fine paper comprising home, office, converting, and professional printing papers; and market pulp. It serves customers in the agriculture, automotive, building and construction, chemicals, food and beverages, home and personal care, pet care, retail, and shipping and transport industries. The company was incorporated in 2007 and is based in Weybridge, the United Kingdom.

Pharma Mar stock logo

Pharma Mar OTCMKTS:PHMMF

$104.49 0.00 (0.00%)
As of 06/12/2025

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.